Interim / Quarterly Report • Nov 18, 2025
Interim / Quarterly Report
Open in ViewerOpens in native device viewer

Octopus AIM VCT plc (the 'Company') is a venture capital trust (VCT) which aims to provide shareholders with attractive tax-free dividends and long-term capital growth by investing in a diverse portfolio of predominantly AIM-traded companies. The Company is managed by Octopus Investments Limited ('Octopus' or the 'Investment Manager').
| Financial summary | 1 |
|---|---|
| Key dates | 1 |
| Interim management report | |
| Chair's statement | 2 |
| Investment Manager's review | 4 |
| Investment policy | 6 |
| Investment portfolio | 7 |
| Directors' responsibilities statement | 13 |
| Income statement | 14 |
| Balance sheet | 15 |
| Statement of changes in equity | 16 |
| Cash flow statement | 19 |
| Condensed notes to the financial statements | 20 |
| About Octopus AIM VCT plc | 24 |
| Shareholder information and contact details | 25 |
| Directors and advisers | 26 |
| Glossary of terms | 27 |
| Six months to 31 August 2025 |
Six months to 31 August 2024 |
Year to 28 February 2025 |
|
|---|---|---|---|
| Net assets (£'000) | 112,277 | 117,750 | 115,383 |
| (Loss)/Profit after tax (£'000) | (522) | 2,521 | (6,079) |
| Net asset value (NAV) per share (p) | 47.8 | 57.2 | 50.6 |
| Total return per share (%)1 | (0.6) | 2.1 | (4.4) |
| Dividends per share paid in the period (p) | 2.5 | 7.4 | 9.9 |
| Dividend per share declared (p)2 | 2.5 | 2.5 | 2.5 |
Interim dividend payment date 27 January 2026
Annual results to 28 February 2026 June 2026
Interim results to 31 August 2026 November 2026
1 Total return is an alternative performance measure calculated as movement in NAV per share in the period plus dividends paid in the period, divided by the NAV per share at the beginning of the period.
2 The interim dividend of 2.5p will be paid on 27 January 2026 to those shareholders on the register on 30 December 2025.
The six months to 31 August 2025 commenced amid considerable turbulence, with geopolitical uncertainty following "Liberation Day" weighing heavily on investor sentiment and overall market confidence. The AIM market's performance at the start of the period was subdued, reflecting these pressures and investor concerns about the challenges affecting AIM. As the period progressed, both AIM and the broader UK capital market made good progress with volatility falling and market participants becoming more optimistic amid encouraging tariff negotiations.
At the start of the period, IPO (initial public offering) and follow-on fundraising activity was subdued, reflecting the understandable caution of companies operating within a volatile macroeconomic environment. Encouragingly, this pause proved temporary as momentum gradually improved, with capital markets rebounding on recovering confidence. Towards the end of the period and post the half-year end a new wave of ambitious, innovative companies has emerged, seeking growth capital and adding fresh energy to an increasingly healthy pipeline of IPO candidates and secondary fundraisings.
Despite this gradual improvement in market sentiment, investors remained selective and cautious, particularly regarding smaller, high-growth businesses. This caution weighed on valuations and contributed to the Company's 0.6% decline in Net Asset Value (NAV) after accounting for the final dividend of 2.5p, and lagging the AIM Index, which rose 9.7% over the period. The divergence in relative performance was largely due to the portfolio's limited exposure to the mining and financial sectors, which drove much of the AIM Index's gains. Many companies in these sectors do not qualify for VCT funding and are therefore not held in the portfolio. This is covered in more detail in the Investment Manager's Review. Looking forward, early signs of recovery and a gradual return in investor confidence provide a foundation for optimism that performance will improve over time.
Encouragingly, policy support continued to provide a reassuring backdrop. The government's reaffirmation of its commitment to Venture Capital Trusts in the Spring Statement demonstrated encouraging support for the channelling of patient, long-term growth capital to UK enterprises. The Chancellor's Mansion House speech was also well received as she reiterated government support for the direction of investment into productive growth sectors, which should further strengthen the foundation for the UK's dynamic small and mid-cap markets. Together, these signals point towards a
cautiously brighter outlook defined by recovery, resilience, and renewal across AIM and the wider UK economy.
Details of amounts paid to the Investment Manager are disclosed in Note 8 to the half-yearly report.
During the six months to 31 August 2025, the Company repurchased 4,653,994 Ordinary shares at a total cost of £2,205,000. Shareholder feedback gathered by the Investment Manager continues to highlight the importance of this buyback facility to investors. The Board remains committed to maintaining its policy of repurchasing shares at a discount of up to 5% of NAV to the selling shareholder.
In this period 11,164,307 new shares were issued, 2,227,986 of these being issued through the Dividend Reinvestment Scheme (DRIS).
On 28 August 2025, the Company paid a final dividend of 2.5p per share for the financial year ended 28 February 2025. For the period to 31 August 2025, the Board has declared an interim dividend of 2.5p per share, to be paid on 27 January 2026 to shareholders on the register as at 30 December 2025. This is consistent with the Company's current dividend policy, which targets a minimum annual dividend payment of 5.0p per share or a 5% yield based on the prior year-end share price, whichever is higher. Dividends are typically paid in two instalments each year.
To support the Company's long-term sustainability and ensure it remains well positioned to deliver value for shareholders, the Board has undertaken a review of the current dividend policy. This follows a prolonged period of market volatility, together with a sustained record of high dividend distributions, both of which have together contributed to a reduction in the Net Asset Value (NAV) per share over time.
As a result, from the financial year ended February 2027 onward, a revised dividend policy will be implemented, commencing with the interim dividend payable around January 2027. Under the new dividend policy, the Company will target an annual dividend equivalent to 6% of the opening NAV per share, with the flexibility to distribute additional special dividends in the event of significant portfolio realisations.
This approach is intended to provide shareholders with a reliable stream of tax-free dividends while supporting the Company's capacity for long-term investment growth. It also ensures that, when larger profitable exits occur, shareholders remain well positioned to continue to benefit from material beneficial exits through special dividends, an area in which the Company has consistently delivered strong performance. The Board believes this revised policy achieves the right balance between providing regular returns to shareholders and maintaining the financial strength required to support future value creation.
As outlined in the Annual Report and Accounts for the year ended 28 February 2025, Neal Ransome, who served as a director for nine years and as Chair since 2021, stepped down from the Board following the Annual General Meeting on 23 July 2025. I would like to extend my sincere thanks to Neal for his significant contribution and leadership during his tenure. I am pleased to welcome David Docherty to the Board as a director with effect from 23 July 2025. David brings extensive asset management experience, having held a range of senior roles as both a portfolio manager and investment director.
The principal risks and uncertainties are set out in Note 7 to the half-yearly report on page 21.
Investors appear cautiously optimistic about UK capital markets. IPO activity and secondary fund raising are beginning to improve, though confidence remains measured ahead of the Autumn Budget. At the same time, current valuations across the AIM market remain low, which is increasingly being viewed as an attractive entry point by long term investors seeking exposure to high growth UK businesses. The proposed reforms could also prove beneficial for AIM VCTs by directing more capital towards these innovative companies. If enacted, we expect these changes to help stimulate IPOs and secondary fund raising, strengthening the broader market's resilience and longer term stability. We believe your Investment Manager is well positioned to invest in new opportunities as they arise.
Joanne Parfrey Chair 18 November 2025
Since March 2025, the AIM market and broader UK economy have shown tentative but sustained signs of recovery supported by improving macroeconomic fundamentals and resilient corporate trading performance. Despite ongoing geopolitical and market uncertainties, growth has remained steady with the UK amongst the fastest growing G7 nations, demonstrating reassuring resilience amid global volatility. This recovery is supported by robust performance in key sectors such as services and manufacturing. Additionally, inflation has continued to trend downward enabling the Bank of England to make successive interest rate cuts in May and August with further cuts expected in the near term. Coupled with modest improvements in business confidence and investment growth, these factors have stimulated renewed equity market activity, improved investor sentiment and a modest rebound in capital market transactions.
Encouragingly, many AIM companies in your portfolio reported strong earnings growth during the review period, underscoring AIM's crucial role as a platform for innovative small to midsized growth businesses. While capital outflows and corporate delistings continue to present challenges, new IPOs and secondary fundraisings have cautiously resumed. Additionally, public recognition of the vital role AIM VCTs play in financing these growth companies was emphasised in the 2025 Spring Budget and Mansion House statements, which highlighted VCTs as key vehicles for channelling capital into UK innovation.
Building on this, the Venture Capital Trust Association (VCTA) has submitted a comprehensive reform proposal to HM Treasury, advocating for a modernisation of VCT rules. Key recommendations include increasing the annual investment limit to £6.5 million and the lifetime limit to £16 million, with higher thresholds for Knowledge Intensive Companies. The proposal also suggests extending the company age eligibility from seven to ten years, and up to 13 years for Knowledge Intensive firms, having secured the scheme's continuation until at least 2035. Designed to counteract inflation's erosion of investment limits and to broaden regional and sectoral support, these reforms aim to ensure VCTs remain essential vehicles for financing high-growth sectors like technology and life sciences. Importantly, the proposed changes are expected to be low cost or cost-neutral to the Exchequer, preserving VCTs' vital role in driving UK innovation and job creation amid varying economic conditions. We strongly welcome these proposals, which have the potential to positively transform the sector.
Over the six months to 31 August 2025, the NAV declined by 0.6% on a total return basis, compared to a 9.7% increase in the AIM Index, a 11.8% rise in the FTSE Small Cap Index (excluding
Investment Trusts), and a 7.1% gain in the FTSE All Share Index, all on a total return basis. The AIM Index's performance was largely driven by the precious metals and mining sectors, benefiting from higher commodity prices, particularly gold, which, as a significant sector weight, had an outsized effect. In contrast, the FTSE All Share Index's growth was supported by a broader range of sectors including financials, aerospace and defence, and consumer staples. The financial sector gains were mainly led by banks, while aerospace and defence saw increased investor interest amid ongoing geopolitical uncertainties. Tobacco was the main contributor within consumer staples. The FTSE Small Cap Index (ex-Investment Trusts) was boosted by strong sector performance of financials, mining, and specialty retail, which experienced resilient demand. Your portfolio underperformed primarily due to its limited exposure to top-performing sectors such as mining and financials, which generally are outside of VCT qualification criteria. While the AIM Index remains the most appropriate benchmark, it is worth noting that a considerable portion of it lies outside our investable universe.
Several companies contributed positively to performance during the period. Haydale Graphene Industries plc made strong commercial progress with its graphene-based JustHeat product line, securing commitments for over 40 pilot installations across Welsh housing providers and signing a strategic UKwide distribution agreement with Quidos Protect, a network of qualified heating engineers. JustHeat also received UL (Underwriters Laboratories) certification, enabling commercial sales in the US and Canada, significantly expanding its market opportunity. SDI Group plc delivered on full-year market expectations, driven by improved second-half demand and a solid order book despite macroeconomic challenges. The company also announced a £4.75 million acquisition of Severn Thermal Solutions, expected to be immediately earnings enhancing. Craneware plc was the subject of a bid from Bain Capital at a premium to the prevailing share price. Although the Board rejected the approach, it has sharpened investor focus on the company's fundamental value. Aurrigo International plc provided encouraging updates on their autonomous vehicle division, including the launch of AutoCargo (an autonomous vehicle developed with UPS to transport heavy cargo) and announced a strategic partnership with Swissport to deploy its technology at Zurich Airport.
Among the detractors during the period was GB Group plc, whose share price faced downward pressure mainly due to cautious sentiment around US spending. Despite this, the company continued to trade broadly in line with market expectations, supported by steady operational progress and initiatives to strengthen its US identity business. The company's announcement of its intention to move from AIM
to the Main Market by 30 October introduced additional selling pressure, temporarily depressing the share price. GENinCode plc faced delays in FDA approval for its tests, which, while frustrating, there still remains significant growth opportunities for the business in its market. RC Fornax plc downgraded its revenue expectations after failing to convert its pipeline, a disappointing update from a company that listed with strong growth ambitions and seemed well positioned to benefit from increased defence spending. Beek Financial Cloud announced a strategic shift towards a revenue-share model, intended to boost long-term profitability. However, this approach involves greater commercial risk, which was poorly received by the market. Despite this, the business remains well positioned for growth, recently securing significant Proximity Cloud wins and renewals worth approximately \$10 million.
During the period under review, the Company made one qualifying investment totalling £0.1 million, a decrease from the £2.1 million invested in the same period last year. This investment was a follow-on into Aurrigo International plc, a specialist in designing and developing fully integrated smart airside solutions for the aviation industry. Aurrigo successfully raised £14 million during the period, led by a strategic investor, Next Gen Mobility, leaving the company well capitalised to accelerate its growth trajectory with a focus on expanding its autonomous vehicle portfolio and airport deployments globally.
We invested £0.6 million in Applied Nutrition plc, a UK-based developer and seller of sports nutrition and wellness products. The company serves both domestic and international markets through retail and wholesale channels. The investment in this non-qualifying Main List company is part of our liquidity management strategy and aims to increase exposure to UK equities where valuations appear significantly undervalued. Applied Nutrition has demonstrated strong momentum, with H1 2025 revenue of £47.6 million, exceeding IPO guidance, and year-on-year normalised growth of approximately 19%. The company is well positioned for sustained growth supported by expanding distribution across the UK and Europe, new customer wins, and a growing direct-to-consumer channel, presenting an excellent entry point with potential for significant multi-year returns. Furthermore, the portfolio continues to hold certain existing non-qualifying AIM investments where we see potential for further share price appreciation. During the year, we partially disposed of our holding in the FP Octopus UK Multi Cap Income Fund, realising proceeds of £0.7 million.
Over the period, disposals generated a net gain of £10 million over book cost and produced cash proceeds of £16.8 million. Partial sales were made in Sosandar plc, Next 15 Group plc,
Applied Nutrition plc, and Gooch & Housego plc. We also fully exited nine holdings, including Ricardo plc, Breedon Group plc, Intelligent Ultrasound Group plc, Learning Technologies Group plc, RWS Holdings plc, Restore plc, Maxcyte Inc., Advanced Medical Solutions Group plc, and RC Fornax plc. The sale of Breedon Group (as a result of the company moving to the Main List in 2023), was a standout trade, delivering approximately a 6.5x return and realising substantial profits. This exemplifies the success of our long-term investment strategy and the value it can create for shareholders over time.
At the end of the period, 30.3% of the Company's net assets were held in cash or collective investment funds providing short-term liquidity reflective of the recent disposals.
As stated in the investment policy on page 6, the Company is able to make investments in unquoted companies intending to float. At 31 August 2025, 11.1% (31 August 2024: 8.7% and 28 February 2025: 13.2%) of the Company's net assets were invested in unquoted companies.
The decrease since the year end is driven by the disposal of Intelligent Ultrasound Group, an AIM company which had been temporarily reclassified as unquoted before being sold early in the period, excluding this the value of unquoted investments has increased. This uplift reflects the higher valuation of Hasgrove, which has continued to trade strongly operationally.
The UK's economic outlook through the end of 2025 and into 2026 is characterised by modest growth amid ongoing geopolitical and political uncertainties. Despite this backdrop, AIM is showing renewed strength, with both IPO and secondary fundraising activity steadily gaining momentum as investor confidence gradually returns. Market sentiment remains slightly cautious ahead of the Autumn Budget, where potential tax changes could impact market dynamics. Proposed VCT reforms are expected to enhance AIM's appeal by increasing the pools of capital for small businesses, and in turn supporting a robust pipeline of IPOs in the years ahead. Collectively, these factors contribute to a balanced outlook for UK equity markets, blending near-term challenges with stronger structural foundations for sustained growth. Encouragingly, since the period end, your portfolio has invested £1.1 million, with a promising pipeline of new potential investments continuing to develop.
The Octopus Quoted Companies team Octopus Investments 18 November 2025
The Company's investment policy has been designed and updated to ensure continued compliance with the VCT qualifying conditions. The Board intends that the long-term disposition of the Company's assets will be at least 85% in a portfolio of qualifying AIM and Aquis Stock Exchange traded investments or unquoted companies where the management views an initial public offering (IPO) on AIM or the Aquis Stock Exchange as a short to medium term objective.
The non-qualifying balance will be invested in permitted investments held for short term liquidity, generally comprising short-term cash or money market deposits with a minimum Moody's long-term debt rating of 'A'. A proportion of the balance could be invested in funds managed by Octopus or other direct equity investments. This provides a reserve of liquidity which should maximise the Company's flexibility as to the timing of investments, disposals, dividend payments and share buybacks.
Risk is spread by investing in a number of different businesses across a range of industry sectors. The maximum amount invested in any one company is limited to the amount permitted pursuant to VCT legislation in a fiscal year and no more than 15% of the Company as measured by HMRC value.
The value of an individual investment is expected to increase over time as a result of trading progress and a continuous assessment is made of its suitability for sale. However, Shareholders should be aware that the Company's qualifying investments are held with a view to long-term capital growth as well as income and will often have limited marketability; as a result it is possible that individual holdings may grow in value to the point where they represent a significantly higher proportion of total assets prior to a realisation opportunity being available.
The Company's Articles permit borrowings of amounts up to 10% of the adjusted share capital and reserves (as defined in the Company's Articles). However, investments will normally be made using the Company's equity Shareholders' funds and it is not intended that the Company will take on any borrowings.
| Portfolio company | Sector | Book cost as at 31 August 2025 £'000 |
Cumulative change in fair value £'000 |
Fair value as at 31 August 2025 £'000 |
Movement in period £'000 |
% equity held by Octopus AIM VCT plc |
% equity held by all funds managed by Octopus |
Fair value as a % of Octopus AIM VCT's NAV |
|---|---|---|---|---|---|---|---|---|
| Quoted investments | ||||||||
| Netcall plc | Software and Computer Services |
308 | 3,186 | 3,494 | 148 | 1.78% | 6.39% | 3.11% |
| Craneware plc | Health Care Providers | 183 | 2,784 | 2,967 | 428 | 0.39% | 7.59% | 2.64% |
| Brooks Macdonald Group plc |
Investment Banking and Brokerage Services |
746 | 2,022 | 2,768 | 350 | 0.98% | 1.62% | 2.47% |
| Judges Scientific plc | Electronic and Electrical Equipment |
236 | 2,242 | 2,478 | (576) | 0.57% | 0.95% | 2.21% |
| IDOX plc | Software and Computer Services |
311 | 2,088 | 2,399 | 41 | 0.90% | 16.06% | 2.14% |
| SDI Group plc | Electronic and Electrical Equipment |
179 | 1,830 | 2,009 | 647 | 2.13% | 3.56% | 1.79% |
| GB Group plc | Software and Computer Services |
505 | 1,311 | 1,816 | (823) | 0.33% | 6.84% | 1.62% |
| Beeks Financial Cloud Group plc |
Software and Computer Services |
405 | 1,338 | 1,743 | (543) | 1.20% | 2.01% | 1.55% |
| Aurrigo International plc Technology Hardware | and Equipment | 1,657 | 36 | 1,693 | – | 4.06% | 11.80% | 1.51% |
| Diaceutics plc | Health Care Providers | 930 | 722 | 1,652 | (98) | 1.44% | 2.86% | 1.47% |
| Vertu Motors plc | Retailers | 1,265 | 322 | 1,587 | 197 | 0.83% | 1.42% | 1.41% |
| PCI-Pal plc | Software and Computer Services |
1,294 | 279 | 1,573 | (529) | 4.68% | 8.97% | 1.40% |
| Animalcare Group plc | Pharmaceuticals and Biotechnology |
306 | 1,114 | 1,420 | 176 | 0.80% | 2.07% | 1.26% |
| Haydale Graphene Industries plc |
Industrial Materials | 1,857 | (470) | 1,387 | 1,135 | 5.83% | 9.72% | 1.24% |
| Windar Photonics plc | Electronic and Electrical Equipment |
936 | 328 | 1,264 | 281 | 2.43% | 4.05% | 1.13% |
| EKF Diagnostics Holdings plc |
Medical Equipment and Services |
767 | 470 | 1,237 | 321 | 0.97% | 1.77% | 1.10% |
| Ixico plc | Pharmaceuticals and Biotechnology |
1,651 | (438) | 1,213 | 253 | 10.91% | 18.18% | 1.08% |
| Gear4music (Holdings) plc |
Leisure Goods | 529 | 407 | 936 | 403 | 1.81% | 3.02% | 0.83% |
| Wise plc | Industrial Support Services |
545 | 266 | 811 | 47 | 0.01% | 0.02% | 0.72% |
| Itaconix plc | General Industrials | 1,588 | (778) | 810 | – | 4.62% | 9.84% | 0.72% |
| Portfolio company | Sector | Book cost as at 31 August 2025 £'000 |
Cumulative change in fair value £'000 |
Fair value as at 31 August 2025 £'000 |
Movement in period £'000 |
% equity held by Octopus AIM VCT plc |
% equity held by all funds managed by Octopus |
Fair value as a % of Octopus AIM VCT's NAV |
|---|---|---|---|---|---|---|---|---|
| Ilika plc | Electronic and Electrical Equipment |
1,058 | (256) | 802 | (84) | 1.17% | 4.12% | 0.71% |
| Nexteq plc | Technology Hardware and Equipment |
507 | 286 | 793 | 33 | 1.84% | 3.07% | 0.70% |
| Applied Nutrition plc | Food Producers | 595 | 183 | 778 | 146 | 0.19% | 0.55% | 0.69% |
| Eden Research plc | Chemicals | 1,620 | (848) | 772 | – | 4.67% | 7.79% | 0.69% |
| Gamma Communications plc |
Telecommunications Service Providers |
274 | 481 | 755 | (191) | 0.08% | 0.73% | 0.67% |
| JTC plc | Investment Banking and Brokerage Services |
601 | 119 | 720 | 122 | 0.04% | 0.11% | 0.64% |
| Cranswick plc | Food Producers | 606 | 83 | 689 | 28 | 0.02% | 0.06% | 0.61% |
| Oberon Investments Group plc |
Investment Banking and Brokerage Services |
864 | (183) | 681 | (110) | 2.35% | 7.85% | 0.61% |
| Cambridge Cognition Holdings plc |
Health Care Providers | 1,075 | (442) | 633 | (204) | 4.44% | 7.40% | 0.56% |
| Equipmake Holdings plc Electronic and | Electrical Equipment | 2,121 | (1,496) | 625 | 264 | 4.28% | 7.13% | 0.56% |
| Pulsar Group plc | Software and Computer Services |
678 | (57) | 621 | (111) | 1.17% | 2.01% | 0.55% |
| Abingdon Health plc | Medical Equipment and Services |
1,615 | (1,027) | 588 | (235) | 6.08% | 10.13% | 0.52% |
| GSK plc | Pharmaceuticals and Biotechnology |
603 | (54) | 549 | (5) | 0.00% | 0.00% | 0.49% |
| Sosandar plc | Retailers | 1,452 | (979) | 473 | 97 | 3.81% | 6.35% | 0.42% |
| Next 15 Group plc | Media | 364 | 95 | 459 | (64) | 0.17% | 12.06% | 0.41% |
| Bloomsbury Publishing plc |
Media | 629 | (190) | 439 | (110) | 0.11% | 1.44% | 0.39% |
| DP Poland plc | Travel and Leisure | 1,016 | (590) | 426 | 14 | 0.50% | 0.84% | 0.38% |
| Mears Group plc | Industrial Support Services |
139 | 280 | 419 | (29) | 0.14% | 0.16% | 0.37% |
| GENinCode plc | Medical Equipment and Services |
2,481 | (2,069) | 412 | (724) | 11.06% | 18.43% | 0.37% |
| Gooch & Housego plc | Technology Hardware and Equipment |
305 | 66 | 371 | 32 | 0.28% | 11.80% | 0.33% |
| Bytes Technology Group plc |
Software and Computer Services |
489 | (133) | 356 | (14) | 0.04% | 0.13% | 0.32% |
| Portfolio company | Sector | Book cost as at 31 August 2025 £'000 |
Cumulative change in fair value £'000 |
Fair value as at 31 August 2025 £'000 |
Movement in period £'000 |
% equity held by Octopus AIM VCT plc |
% equity held by all funds managed by Octopus |
Fair value as a % of Octopus AIM VCT's NAV |
|---|---|---|---|---|---|---|---|---|
| Tan Delta Systems plc | Electronic and Electrical Equipment |
453 | (105) | 348 | 35 | 2.38% | 3.97% | 0.31% |
| KRM22 plc | Software and Computer Services |
681 | (374) | 307 | 143 | 1.91% | 3.18% | 0.27% |
| GETECH Group plc | Oil, Gas and Coal | 300 | (45) | 255 | (30) | 9.84% | 16.40% | 0.23% |
| Rosslyn Data Technologies plc |
Software and Computer Services |
1,169 | (928) | 241 | (44) | 8.56% | 14.26% | 0.21% |
| TPXimpact Holdings plc Software and | Computer Services | 979 | (761) | 218 | (99) | 1.42% | 2.37% | 0.19% |
| MyCelx Technologies Corporation |
Electronic and Electrical Equipment |
1,470 | (1,258) | 212 | (41) | 3.34% | 23.50% | 0.19% |
| Velocity Composites plc Aerospace and Defense | 799 | (602) | 197 | (47) | 1.72% | 2.87% | 0.18% | |
| Staffline Group plc | Industrial Support Services |
334 | (166) | 168 | 53 | 0.29% | 0.29% | 0.15% |
| Gelion plc | Electronic and Electrical Equipment |
1,140 | (983) | 157 | 59 | 0.44% | 0.74% | 0.14% |
| Creo Medical Group plc | Medical Equipment and Services |
1,471 | (1,318) | 153 | (15) | 0.29% | 1.49% | 0.14% |
| ENGAGE XR Holdings plc |
Software and Computer Services |
1,879 | (1,733) | 146 | (39) | 2.94% | 12.14% | 0.13% |
| Feedback plc | Medical Equipment and Services |
1,500 | (1,369) | 131 | (45) | 2.30% | 4.46% | 0.12% |
| Fusion Antibodies plc | Health Care Providers | 745 | (616) | 129 | 62 | 0.79% | 1.31% | 0.11% |
| Crimson Tide plc | Software and Computer Services |
567 | (454) | 113 | (38) | 2.87% | 4.79% | 0.10% |
| DXS International plc | Software and Computer Services |
300 | (225) | 75 | (19) | 5.86% | 9.76% | 0.07% |
| XP Factory plc | Travel and Leisure | 988 | (919) | 69 | (11) | 0.42% | 0.70% | 0.06% |
| Verici Dx plc | Pharmaceuticals and Biotechnology |
1,551 | (1,487) | 64 | (289) | 0.85% | 1.42% | 0.06% |
| Strip Tinning Holdings plc |
Electronic and Electrical Equipment |
506 | (448) | 58 | (3) | 1.50% | 2.50% | 0.05% |
| 1Spatial plc | Software and Computer Services |
300 | (257) | 43 | (16) | 0.08% | 5.85% | 0.04% |
| Northcoders Group plc | Software and Computer Services |
380 | (342) | 38 | (104) | 1.58% | 2.63% | 0.03% |
| TheraCryf plc | Pharmaceuticals and Biotechnology |
1,050 | (1,020) | 30 | (3) | 0.61% | 1.02% | 0.03% |
| Portfolio company | Sector | Book cost as at 31 August 2025 £'000 |
Cumulative change in fair value £'000 |
Fair value as at 31 August 2025 £'000 |
Movement in period £'000 |
% equity held by Octopus AIM VCT plc |
% equity held by all funds managed by Octopus |
Fair value as a % of Octopus AIM VCT's NAV |
|---|---|---|---|---|---|---|---|---|
| Bow Street Group plc | Travel and Leisure | 516 | (509) | 7 | (1) | 0.62% | 1.19% | 0.01% |
| Genedrive Plc | Pharmaceuticals and Biotechnology |
217 | (216) | 1 | (4) | 0.03% | 0.04% | 0.00% |
| Metir plc | Electronic and Electrical Equipment |
1,384 | (1,384) | – | – | 0.01% | 0.02% | 0.00% |
| Sorted Group Holdings Plc |
Software and Computer Services |
763 | (763) | – | – | 0.01% | 0.01% | 0.00% |
| Trackwise Designs plc | Technology Hardware and Equipment |
1,934 | (1,934) | – | – | 0.42% | 0.70% | 0.00% |
| Cloudified Holdings Limited |
Software and Computer Services |
900 | (900) | – | – | 2.02% | 3.36% | 0.00% |
| Enteq technologies plc | Oil, Gas and Coal | 1,032 | (1,032) | – | (21) | 0.99% | 1.65% | 0.00% |
| ReNeuron Group plc | Pharmaceuticals and Biotechnology |
1,485 | (1,485) | – | – | 3.03% | 5.06% | 0.00% |
| The British Honey Company plc |
General Retailers | 1,321 | (1,321) | – | – | 7.12% | 11.86% | 0.00% |
| LungLife AI Inc | Pharmaceuticals and Biotechnology |
2,079 | (2,079) | – | (15) | 3.85% | 6.42% | 0.00% |
| Libertine Holdings plc | Industrial Engineering | 3,000 | (3,000) | – | – | 0.00% | 0.00% | 0.00% |
| Total quoted investments | 68,483 | (17,705) | 50,778 | 181 | 45.22% | |||
| Unquoted investments | ||||||||
| Hasgrove Ltd | 88 | 8,123 | 8,211 | 193 | 2.84% | 17.07% | 7.31% | |
| Popsa Holdings Ltd | 1,590 | 2,379 | 3,969 | (238) | 6.23% | 10.39% | 3.54% | |
| Alusid Limited | 300 | – | 300 | 60 | 3.14% | 5.23% | 0.27% | |
| Airnow Ltd | 1,257 | (1,257) | – | – | 0.41% | 0.73% | 0.00% | |
| Rated People Ltd | 354 | (354) | – | – | 0.11% | 0.32% | 0.00% | |
| The Food Marketplace Ltd |
300 | (300) | – | – | 6.60% | 10.99% | 0.00% | |
| Total unquoted investments | 3,889 | 8,591 | 12,480 | 15 | 11.12% |
| Portfolio company | Sector | Book cost as at 31 August 2025 £'000 |
Cumulative change in fair value £'000 |
Fair value as at 31 August 2025 £'000 |
Movement in period £'000 |
% equity held by Octopus AIM VCT plc |
% equity held by all funds managed by Octopus |
Fair value as a % of Octopus AIM VCT's NAV |
|---|---|---|---|---|---|---|---|---|
| Loan note investments | ||||||||
| Strip Tinning Holdings plc |
Electronic and Electrical Equipment |
900 | – | 900 | – | N/A | N/A | 0.80% |
| Haydale Graphene Industries plc |
Industrial Materials | 300 | – | 300 | – | N/A | N/A | 0.27% |
| Total loan notes | 1,200 | – | 1,200 | – | 1.07% | |||
| Current asset investments | ||||||||
| FP Octopus UK Micro Cap Growth Fund |
8,118 | 429 | 8,547 | 351 | N/A | N/A | 7.61% | |
| FP Octopus UK Multi Cap Income Fund |
2,868 | 715 | 3,583 | 124 | N/A | N/A | 3.19% | |
| FP Octopus UK Future Generations Fund |
2,076 | (111) | 1,965 | (10) | N/A | N/A | 1.75% | |
| Total current asset investments | 13,062 | 1,033 | 14,095 | 465 | 12.55% | |||
| Total fixed and current asset investments | 78,553 | 69.96% | ||||||
| Money market funds | 31,486 | 28.04% | ||||||
| Cash at bank | 2,516 | 2.24% | ||||||
| Debtors less creditors | (278) | (0.25%) | ||||||
| Total net assets | 112,277 | 100.00% |
The graph below shows the top ten sectors the equity portfolio was invested in by value as at 31 August 2025. It also shows the sectors of the AIM Market as a whole as at 31 August 2025.

AIM VCT PLC The graph below shows the top ten sectors the equity portfolio was invested in by value as at 31 August 2024. It also shows the sectors of the AIM Market as a whole as at 31 August 2024:

AIM VCT PLC 1 Other sector include Leisure Goods, Media, General Industrials, Chemicals, Telecommunications Service Providers, Travel and Leisure, Oil, Gas and Coal, Aerospace and Defense, Industrial Support Services, Industrial Materials, General Retailers and Industrial Engineering.
We confirm that to the best of our knowledge:
By Order of the Board
Joanne Parfrey
Chair
18 November 2025
| Unaudited Six months to 31 August 2025 |
Unaudited Six months to 31 August 2024 |
Audited Year to 28 February 2025 |
|||||||
|---|---|---|---|---|---|---|---|---|---|
| Revenue £'000 |
Capital £'000 |
Total £'000 |
Revenue £'000 |
Capital £'000 |
Total £'000 |
Revenue £'000 |
Capital £'000 |
Total £'000 |
|
| (Loss)/gain on disposal of fixed asset investments |
– | (1,125) | (1,125) | – | (41) | (41) | – | 1,059 | 1,059 |
| Gain on disposal of current asset investments |
– | 1 | 1 | – | – | – | – | – | – |
| Gain/(loss) on valuation of fixed asset investments |
– | 196 | 196 | – | 713 | 713 | – | (6,264) | (6,264) |
| Gain/(loss) on valuation of current asset investments |
– | 465 | 465 | – | 1,851 | 1,851 | – | (352) | (352) |
| Investment income | 1,225 | – | 1,225 | 1,370 | – | 1,370 | 2,209 | – | 2,209 |
| Investment management fees | (245) | (733) | (978) | (270) | (810) | (1,080) | (518) | (1,561) | (2,079) |
| Other expenses | (306) | – | (306) | (292) | – | (292) | (652) | – | (652) |
| Profit/(loss) before tax | 674 | (1,196) | (522) | 808 | 1,713 | 2,521 | 1,039 | (7,118) | (6,079) |
| Tax | – | – | – | – | – | – | – | – | – |
| Profit/(loss) after tax | 674 | (1,196) | (522) | 808 | 1,713 | 2,521 | 1,039 | (7,118) | (6,079) |
| Earnings per share – basic and diluted |
0.3p | (0.5p) | (0.2p) | 0.4p | 0.8p | 1.2p | 0.5p | (3.4p) | (2.9p) |
The Company has no recognised gains or losses other than the results for the period as set out above. Accordingly, a statement of comprehensive income is not required.
| Unaudited As at 31 August 2025 |
Unaudited As at 31 August 2024 |
Audited As at 28 February 2025 |
||||
|---|---|---|---|---|---|---|
| £'000 | £'000 | £'000 | £'000 | £'000 | £'000 | |
| Fixed asset investments | 64,458 | 86,354 | 81,535 | |||
| Current assets: | ||||||
| Investments | 14,095 | 16,155 | 14,283 | |||
| Money market funds | 31,486 | 13,267 | 18,204 | |||
| Debtors | 405 | 266 | 252 | |||
| Applications cash1 | 4 | 5 | 4,350 | |||
| Cash at bank | 2,512 | 2,389 | 2,296 | |||
| 48,502 | 32,082 | 39,385 | ||||
| Creditors: amounts falling due within one year |
(683) | (686) | (5,537) | |||
| Net current assets | 47,819 | 31,396 | 33,848 | |||
| Total assets less current liabilities | 112,277 | 117,750 | 115,383 | |||
| Called-up equity share capital | 2,347 | 2,058 | 2,282 | |||
| Share premium | 21,566 | 20,707 | 16,226 | |||
| Capital redemption reserve | 455 | 369 | 408 | |||
| Special distributable reserve | 110,034 | 107,619 | 118,070 | |||
| Capital reserve realised | (25,470) | (28,174) | (33,351) | |||
| Capital reserve unrealised | 3,004 | 15,735 | 12,081 | |||
| Revenue reserve | 341 | (564) | (333) | |||
| Total equity shareholders' funds | 112,277 | 117,750 | 115,383 | |||
| NAV per share – basic and diluted | 47.8p | 57.2p | 50.6p |
The statements were approved by the Directors and authorised for issue on 18 November 2025 and are signed on their behalf by:

Joanne Parfrey Chair
Company No: 03477519
1 Cash held but not yet allotted.
| Share capital £'000 |
Share premium £'000 |
Capital redemption reserve £'000 |
Special distributable reserves1 £'000 |
Capital reserve realised1 £'000 |
Capital reserve unrealised £'000 |
Revenue reserve1 £'000 |
Total £'000 |
|
|---|---|---|---|---|---|---|---|---|
| As at 1 March 2025 | 2,282 | 16,226 | 408 | 118,070 | (33,351) | 12,081 | (333) | 115,383 |
| Total comprehensive loss for the period |
– | – | – | – | (1,857) | 661 | 674 | (522) |
| Contributions by and distributions to owners: | ||||||||
| Repurchase and cancellation of own shares |
(47) | – | 47 | (2,205) | – | – | – | (2,205) |
| Issue of shares | 112 | 5,619 | – | – | – | – | – | 5,731 |
| Share issue costs | – | (279) | – | – | – | – | – | (279) |
| Dividends paid | – | – | – | (5,831) | – | – | – | (5,831) |
| Total contributions by and distributions to owners |
65 | 5,340 | 47 | (8,036) | – | – | – | (2,584) |
| Other movements: | ||||||||
| Prior years' holding gains now realised |
– | – | – | – | 9,738 | (9,738) | – | – |
| Total other movements | – | – | – | – | 9,738 | (9,738) | – | – |
| As at 31 August 2025 | 2,347 | 21,566 | 455 | 110,034 | (25,470) | 3,004 | 341 | 112,277 |
1 The sum of these reserves is an amount of £84,905,000 (31 August 2024: £98,219,000 and 28 February 2025: £84,386,000) which is considered distributable to shareholders. The Income Taxes Act 2007 restricts distribution of capital from reserves created by the conversion of the share premium account into a special distributable reserve until the third anniversary of the share allotment that led to the creation of that part of the share premium account. As at 31 August 2025, £75,897,000 of the special reserve is distributable under this restriction.
| Share capital £'000 |
Share premium £'000 |
Capital redemption reserve £'000 |
Special distributable reserves £'000 |
Capital reserve realised £'000 |
Capital reserve unrealised £'000 |
Revenue reserve £'000 |
Total £'000 |
|
|---|---|---|---|---|---|---|---|---|
| As at 1 March 2024 | 2,038 | 18,041 | 341 | 124,213 | (24,622) | 10,470 | (1,372) | 129,109 |
| Total comprehensive profit for the period |
– | – | – | – | (851) | 2,564 | 808 | 2,521 |
| Contributions by and distributions to owners: | ||||||||
| Repurchase and cancellation of own shares |
(28) | – | 28 | (1,663) | – | – | – | (1,663) |
| Issue of shares | 48 | 2,666 | – | – | – | – | – | 2,714 |
| Share issue costs | – | – | – | – | – | – | – | – |
| Dividends paid | – | – | – | (14,931) | – | – | – | (14,931) |
| Total contributions by and distributions to owners |
20 | 2,666 | 28 | (16,594) | – | – | – | (13,880) |
| Other movements: | ||||||||
| Prior years' holding losses now realised |
– | – | – | – | (2,701) | 2,701 | – | – |
| Total other movements | – | – | – | – | (2,701) | 2,701 | – | – |
| As at 31 August 2024 | 2,058 | 20,707 | 369 | 107,619 | (28,174) | 15,735 | (564) | 117,750 |
| Share capital £'000 |
Share premium £'000 |
Capital redemption reserve £'000 |
Special distributable reserves £'000 |
Capital reserve realised £'000 |
Capital reserve unrealised £'000 |
Revenue reserve £'000 |
Total £'000 |
|
|---|---|---|---|---|---|---|---|---|
| As at 1 March 2024 | 2,038 | 18,041 | 341 | 124,213 | (24,622) | 10,470 | (1,372) | 129,109 |
| Total comprehensive loss for the year |
– | – | – | – | (502) | (6,616) | 1,039 | (6,079) |
| Contributions by and distributions to owners: | ||||||||
| Repurchase and cancellation of own shares |
(67) | – | 67 | (3,687) | – | – | – | (3,687) |
| Issue of shares | 311 | 17,114 | – | – | – | – | – | 17,425 |
| Share issue costs | – | (864) | – | – | – | – | – | (864) |
| Dividends paid | – | – | – | (20,521) | – | – | – | (20,521) |
| Total contributions by and distributions to owners |
244 | 16,250 | 67 | (24,208) | – | – | – | (7,647) |
| Other movements: | ||||||||
| Cancellation of share premium |
– | (18,065) | – | 18,065 | – | – | – | – |
| Prior years' holding gains now realised |
– | – | – | – | (8,228) | 8,228 | – | – |
| Total other movements | – | (18,605) | – | 18,605 | (8,228) | 8,228 | – | – |
| Balance as at 28 February 2025 |
2,282 | 16,226 | 408 | 118,070 | (33,351) | 12,081 | (333) | 115,383 |
| Unaudited Six months to 31 August 2025 £'000 |
Unaudited Six months to 31 August 2024 £'000 |
Audited Year to 28 February 2025 £'000 |
|
|---|---|---|---|
| Cash flows from operating activities | |||
| (Loss)/profit before tax | (522) | 2,521 | (6,079) |
| Adjustments for: | |||
| (Increase)/decrease in debtors | (153) | 400 | 414 |
| (Decrease)/increase in creditors | (508) | (39) | 466 |
| Loss/(gain) on disposal of fixed assets | 1,125 | 41 | (1,059) |
| (Gain) on disposal of current assets | (1) | – | – |
| (Gain)/loss on valuation of fixed asset investments | (196) | (713) | 6,264 |
| (Gain)/loss on valuation of current asset investments | (465) | (1,851) | 352 |
| Net cash (utilised in)/generated by operating activities | (720) | 359 | 358 |
| Cash flows from investing activities | |||
| Purchase of fixed asset investments | (692) | (6,129) | (11,280) |
| Proceeds from sale of fixed asset investments | 16,840 | 797 | 4,890 |
| Purchase of current asset investments | – | (408) | (1,008) |
| Proceeds from sale of current asset investments | 654 | – | 270 |
| Net cash generated by/(utilised in) investing activities | 16,802 | (5,740) | (7,128) |
| Cash flows from financing activities | |||
| Movement in applications account | (4,346) | 1 | 4,346 |
| Purchase of own shares | (2,205) | (1,663) | (3,687) |
| Proceeds from share issues (net of DRIS) | 3,041 | 24 | 13,678 |
| Share issues costs | (279) | – | (864) |
| Dividends paid (net of DRIS) | (3,141) | (12,241) | (16,774) |
| Net cash (utilised in)/generated by financing activities | (6,930) | (13,879) | (3,301) |
| Increase/(decrease) in cash and cash equivalents | 9,152 | (19,260) | (10,071) |
| Opening cash and cash equivalents | 24,850 | 34,921 | 34,921 |
| Closing cash and cash equivalents | 34,002 | 15,661 | 24,850 |
| Cash and cash equivalents comprise | |||
| Cash at bank | 2,512 | 2,389 | 2,296 |
| Applications cash | 4 | 5 | 4,350 |
| Money market funds | 31,486 | 13,267 | 18,204 |
| Total cash and cash equivalents | 34,002 | 15,661 | 24,850 |
The unaudited financial statements which cover the six months to 31 August 2025 has been prepared in accordance with the Financial Reporting Council's (FRC) Financial Reporting Standard 104 'Interim Financial Reporting' (September 2024) and the Statement of Recommended Practice (SORP) for Investment Companies re–issued by the Association of Investment Companies in July 2022.
The principal accounting policies have remained unchanged from those set out in the Company's 2025 Annual Report and Accounts.
The unaudited financial statements for the six months ended 31 August 2025 does not constitute statutory accounts within the meaning of Section 415 of the Companies Act 2006 and has not been delivered to the Registrar of Companies. The comparative figures for the year ended 28 February 2025 have been extracted from the audited financial statements for that year, which have been delivered to the Registrar of Companies. The independent auditor's report on those financial statements, in accordance with chapter 3, part 16 of the Companies Act 2006, was unqualified. This half-yearly report has not been reviewed by the Company's auditor.
The earnings per share is calculated on the basis of 233,374,216 Ordinary shares (31 August 2024: 202,899,157 and 28 February 2025: 209,959,577), being the weighted average number of shares in issue during the period.
There are no potentially dilutive capital instruments in issue and, therefore, no diluted return per share figures are relevant. The basic and diluted earnings per share are therefore identical.
The net asset value per share is based on net assets as at 31 August 2025 divided by 234,668,999 shares in issue at that date (31 August 2024: 205,846,926 and 28 February 2025: 228,158,686).
| 31 August 2025 |
31 August 2024 |
28 February 2025 |
|
|---|---|---|---|
| Net assets (£'000) |
112,277 | 117,750 | 115,383 |
| Shares in issue | 234,668,999 | 205,846,926 | 228,158,686 |
| Net asset value per share |
47.8p | 57.2p | 50.6p |
The interim dividend declared of 2.5p per Ordinary share will be paid on 27 January 2026 to those shareholders on the register on 30 December 2025.
During the six months ended 31 August 2025 the Company repurchased the following shares.
| Date | No. of shares |
Price (p) | Cost (£) |
|---|---|---|---|
| 20 March 2025 | 1,053,974 | 47.4 | 499,500 |
| 16 April 2025 | 888,536 | 45.4 | 403,400 |
| 15 May 2025 | 590,908 | 47.3 | 279,500 |
| 19 June 2025 | 774,234 | 49.6 | 384,000 |
| 17 July 2025 | 549,397 | 49.8 | 273,600 |
| 21 August 2025 | 796,945 | 45.8 | 365,000 |
| Total | 4,653,994 | 2,205,000 |
The weighted average price of all buybacks during the period was 47.4p per share.
During the six months ended 31 August 2025 the Company issued the following shares.
| Date | No. of shares |
Price (p) | Net proceeds (£) |
|---|---|---|---|
| 27 March 2025 | 8,893,138 | 52.2 | 4,642,000 |
| 22 May 2025 | 43,183 | 50.1 | 22,000 |
| 28 August 2025 (DRIS) |
2,227,986 | 47.9 | 1,067,000 |
| Total | 11,164,307 | 5,731,000 |
The weighted average allotment price of all shares issued during the period was 51.2p per share.
The Company's principal risks are investment performance, VCT qualifying status risk, operational risk, information security, economic and price risk, regulatory and reputational/ legislative risk, liquidity/cash flow risk and valuation risk. These risks, and the way in which they are managed, are described in more detail in the Company's Annual Report and Accounts for the year ended 28 February 2025. The Board has also considered emerging risks, including geo–political protectionism, climate change and cyber security. The Board seeks to mitigate risks by setting policy and reviewing performance. Otherwise, the Company's principal risks and uncertainties have not changed materially since the date of that report.
The Company has employed Octopus Investments Limited throughout the period as Investment Manager. Octopus has also been appointed as Custodian of the Company's investments under a Custodian Agreement. The Company has been charged £978,000 by Octopus as a management fee in the period to 31 August 2025 (31 August 2024: £1,080,000 and 28 February 2025: £2,079,000). The management fee is payable quarterly and is based on 2% of net assets at six– month intervals.
To make sure the Company is not double charged management fees on these products, the Company receives a reduction in the management fee as a percentage of the value of these investments. This amounted to £34,000 in the period to 31 August 2025 (31 August 2024: £43,000 and 28 February 2025: £86,000). For further details please refer to the Company's Annual Report and Accounts for the year ended 28 February 2025.
In the period, Octopus Investments Nominees Limited (OINL) purchased shares in the Company from shareholders to correct administrative issues, on the understanding that shares will be sold back to the Company in subsequent share buybacks at the prevailing market price. As at 31 August 2025, OINL held nil shares (31 August 2024: nil shares and 28 February 2025: nil shares) in the Company as beneficial owner, with a nil book cost (31 August 2024: £nil and 28 February 2025: £nil).
The Company's principal financial assets are its investments and the policies in relation to those assets are set out below.
Purchases and sales of investments are recognised in the financial statements at the date of the transaction (trade date).
These investments will be managed and their performance evaluated on a fair value basis in accordance with a documented investment strategy and information about them has to be provided internally on that basis to the Board. Accordingly, as permitted by FRS 102, the investments are measured as being fair value through profit or loss on the basis that they qualify as a group of assets managed, and whose performance is evaluated, on a fair value basis in accordance with a documented investment strategy. The Company's investments are measured at subsequent reporting dates at fair value.
In the case of investments quoted on a recognised stock exchange, fair value is established by reference to the closing bid price on the relevant date or the last traded price, depending upon convention of the exchange on which the investment is quoted. This is consistent with the International Private Equity and Venture Capital Valuation (IPEV) guidelines.
Gains and losses arising from changes in fair value of investments are recognised as part of the capital return within the Income Statement and allocated to the capital reserve unrealised. All investments are initially recognised at transaction price and subsequently measured at fair value. Changes in fair value are recognised in the Income Statement.
In the preparation of the valuations of assets the Directors are required to make judgements and estimates that are reasonable and incorporate their knowledge of the performance of the companies we invest in.
Paragraph 34.22 of FRS 102 suggests following a hierarchy of fair value measurements for financial instruments measured at fair value in the Balance Sheet, which gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1) and the lowest priority to unobservable inputs (Level 3). This methodology is adopted by the Company and requires disclosure of financial instruments to be dependent on the lowest significant applicable input, as laid out below:
Level 1: The unadjusted, fully accessible and current quoted price in an active market for identical assets or liabilities that an entity can access at the measurement date.
Level 2: Inputs for similar assets or liabilities other than the quoted prices included in Level 1 that are directly or indirectly observable, which exist for the duration of the period of investment.
Level 3: This is where inputs are unobservable, where no active market is available and recent transactions for identical instruments do not provide a good estimate of fair value for the asset or liability.
There have been no reclassifications between levels in the year. The change in fair value for the current and previous year is recognised through the profit and loss account.
| Level 1: Quoted equity investments £'000 |
Level 3: Unquoted investments £'000 |
Total £'000 |
|
|---|---|---|---|
| Cost as at 1 March 2025 | 73,811 | 7,245 | 81,056 |
| Opening unrealised gain at 1 March 2025 | (8,737) | 9,216 | 479 |
| Valuation at 1 March 2025 | 65,074 | 16,461 | 81,535 |
| Purchases at cost | 692 | – | 692 |
| Disposal proceeds | (14,044) | (2,796) | (16,840) |
| Loss on realisation of investments | (1,125) | – | (1,125) |
| Change in fair value in year | 181 | 15 | 196 |
| Closing valuation at 31 August 2025 | 50,778 | 13,680 | 64,458 |
| Cost at 31 August 2025 | 68,483 | 5,089 | 73,572 |
| Closing unrealised gain at 31 August 2025 | (17,705) | 8,591 | (9,114) |
| Valuation at 31 August 2025 | 50,778 | 13,680 | 64,458 |
Level 1 valuations are valued in accordance with the bid– price on the relevant date. Further details of the fixed asset investments held by the Company are shown within the Investment Manager's review.
Level 3 investments are reported at fair value in accordance with FRS 102 Sections 11 and 12, which is determined in accordance with the latest IPEV guidelines. In estimating fair value, there is an element of judgement, notably in deriving reasonable assumptions, and it is possible that, if different assumptions were to be used, different valuations could have been attributed to some of the Company's investments.
Level 3 investments include £1,200,000 (31 August 2024: £1,080,000 and 28 February 2025: £1,200,000) of convertible loan notes held at cost, which is deemed to be current fair value. In addition to this the Company holds six unquoted investments which are classified as level 3 in terms of fair value hierarchy. These are valued based on a range of valuation methodologies, determined on an investment specific basis. The price of recent investment is used where a transaction has occurred sufficiently close to the reporting date to make this the most reliable indicator of fair value. Where recent investment is not deemed to indicate the most reliable indicator of fair value i.e. the most recent investment is too distant from the reporting date for this to be deemed a reasonable indicator, other market–based approaches including earnings multiples, annualised recurring revenues, discounted cash flows or net assets are used to determine a fair value for the investments.
All capital gains or losses on investments are classified at FVTPL (fair value through profit or loss). Given the nature of the Company's venture capital investments, the changes in fair value of such investments recognised in these financial statements are not considered to be readily convertible to cash in full at the balance sheet date and accordingly these gains are treated as holding gains or losses.
The following events occurred between the balance sheet date and the signing of these financial statements.
<-- PDF CHUNK SEPARATOR -->
Octopus AIM VCT plc (the 'Company' or 'Fund') was launched as Close AIM VCT PLC in the spring of 1998 and raised £10.1 million from private investors through an issue of Ordinary shares.
Between October 2000 and March 2001 a further £20.0 million was raised through an issue of C shares. Furthermore, between 16 March 2004 and final closing on 5 April 2004 the Company raised £3.3 million by way of a D share issue.
The C Shares were merged and converted into Ordinary shares on 31 May 2004 at a conversion ratio determined by a price mechanism related to the respective net assets per share of both the Ordinary shares and C shares at 29 February 2004 (which resulted in C Shareholders receiving 1.0765 Ordinary shares for each C share held).
A further £15.0 million was raised between 6 January 2005 and 8 April 2005 through an issue of New D shares.
On 31 May 2008, the Ordinary shares converted into D shares at a conversion ratio of 0.5448 D shares for each Ordinary share. All of the D shares were then re–designated into New Ordinary shares.
With effect from 1 August 2008, the management of the Company was transferred to Octopus Investments Limited. On 4 August 2010 the share capital was restructured and each existing Ordinary share of 50p was subdivided into one Ordinary share of 1p and one Deferred share of 49p. The Deferred shares had no economic value and were bought back by the Company for an aggregate amount of 1p and cancelled.
On 12 August 2010, following approval at the Extraordinary General Meeting on 4 August 2010, shareholders of Octopus Phoenix VCT had their shares converted into Octopus AIM VCT shares on a relative net asset value basis using the conversion factor of 0.42972672. On the same day, Octopus Phoenix VCT was placed into members' voluntary liquidation.
The offer for subscription in the prospectus dated 9 July 2010 relating to the issue of new shares in connection with the merger with Octopus Phoenix VCT plc was extended by a supplemental prospectus and closed on 19 April 2011, raising £10 million. A subsequent offer raised £1.9 million, closing on 5 April 2012.
Since 5 April 2012 £219 million has been raised through various share offers launched.
Dividends will be paid by the Registrar on behalf of the Company. Shareholders who wish to have dividends paid directly into their bank account rather than by cheque to their registered address can complete a mandate form for this purpose. Queries relating to dividends, shareholdings and requests for mandate forms should be directed to the Company's Registrar, Computershare Investor Services PLC ('Computershare'), by calling 0370 703 6325 (calls are charged at the standard geographic rate and will vary by provider. Calls from outside the United Kingdom will be charged at the applicable international rate). Computershare Investor Services PLC is open between 9.00am–5.30pm, Monday to Friday, excluding public holidays in England and Wales), or by writing to them at:
The Registrar Computershare Investor Services PLC The Pavilions Bridgwater Road Bristol BS99 6ZZ
The Company's share price can be found on various financial websites, such as www.londonstockexchange.com, by typing 'Octopus AIM' in the 'Quotes Search' box.
The latest share price as at the close of business on 17 November 2025 was 46.4p per Ordinary share.
The Company's Ordinary shares can be bought and sold in the same way as any other company quoted on the London Stock Exchange via a stockbroker. There may be tax implications in respect of selling all or part of your holdings, so shareholders should contact their independent financial adviser if they have any queries.
The Company operates a policy of buying its own shares for cancellation as they become available, and envisages that purchases will be made at up to a 5% discount to the prevailing NAV. The Company is, however, unable to buy back shares directly from shareholders. If you are considering selling your shares or trading in the secondary market, please contact Panmure Liberum Limited.
Panmure Liberum Limited is able to provide details of close periods (when the Company is prohibited from buying in shares) and details of the price at which the Company has bought its shares. Panmure Liberum Limited can be contacted as follows:
Chris Lloyd 020 7886 2716 [email protected] Paul Nolan 020 7886 2717 [email protected]
Communications with shareholders are mailed to the registered address held on the share register. In the event of a change of address or other amendment this should be notified to the Company's Registrar, Computershare, under the signature of the registered holder. Their contact details can be found at the end of this report.
Other information for shareholders
Previously published annual reports and half–yearly reports are available for viewing on the Octopus website at
www.octopusinvestments.com by navigating to Services, Investors, Shareholder information, Octopus AIM VCT plc. All other statutory information will also be found there.
Many companies are aware that their shareholders have received unsolicited phone calls or correspondence concerning investment matters. These are typically from overseas based "brokers" who target UK shareholders offering to sell them what often turn out to be worthless or high risk shares in US or UK investments. They can be very persistent and extremely persuasive. Shareholders are therefore advised to be wary of any unsolicited advice, offer to buy shares at a discount or offer for free company reports.
Please note that it is very unlikely that either Octopus Investments Limited ('Octopus') or the Company's Registrar would make unsolicited telephone calls to shareholders. In any event any such calls would relate only to official documentation already circulated to shareholders and would never be in respect of investment "advice".
If you are in any doubt about the veracity of an unsolicited phone call, please call either Octopus, or the Registrar, at the numbers provided at the back of this report.
Joanne Parfrey (Chair)
Andrew Boteler
Louise Nash
David Docherty (appointed July 2025)
Registered in England No: 03477519
213800C5JHJUQLAFP619
Octopus Company Secretarial Services Limited
33 Holborn
London
EC1N 2HT
Octopus Investments Limited
33 Holborn
London
EC1N 2HT
Tel: 0800 316 2295
www.octopusinvestments.com
Octopus Investments Limited
33 Holborn
London
EC1N 2HT
HSBC Bank plc
31 Holborn
London
EC1N 2HR
BDO LLP
55 Baker Street
London
W1U 7EU
James Cowper Kreston
The White Building
1-4 Cumberland Place
Southampton
SO15 2NP
Shoosmiths LLP
Apex Plaza
Forbury Road
Reading
RG1 1AX
Computershare Investor Services PLC
The Pavilions
Bridgwater Road
Bristol
BS99 6ZZ
Tel: 0370 703 6326
Calls are charged at the standard geographic rate and will vary by provider. Calls from outside the United Kingdom will be charged at the applicable international rate.
www.computershare.com/uk
www-uk.computershare.com/investor/
Panmure Liberum Limited
Ropemaker Place, Level 12
25 Ropemaker Street
London
EC2Y 9LY
Tel: +44 (0)20 3100 2000
A financial measure of historical or future financial performance, financial position or cash flows, other than a financial measure defined or specified in the applicable financial reporting framework. These APMs will help shareholders to understand and assess the Company's progress. A number of terms within this glossary have been identified as APMs.
The value of the VCT's total assets less liabilities. It is equal to the total shareholders' funds.
The NAV per share of the Company is the sum of the underlying assets less the liabilities of the Company divided by the total number of shares in issue.
Total return is calculated as movement in NAV per share in the period plus dividends paid in the period. Total return per share enables shareholders to evaluate more clearly the performance of the Company, as it reflects the underlying value of the portfolio at the reporting date.
Total return % is calculated as movement in NAV per share in the period plus dividends paid in the period, divided by the NAV per share at the beginning of the period. Total return % on the NAV per share enables shareholders to evaluate more clearly the performance of the Company, as it reflects the underlying value of the portfolio at the reporting date.
A mutual fund that invests in highly liquid, short-term instruments. These instruments include cash, cash equivalent securities, and high credit rating debt based securities with a short-term maturity. They are intended to offer investors high liquidity with a low level of risk.
A type of investment fund that invests in equities, bonds and other securities. The price of the shares is based on the underlying assets of the fund. These are highly liquid as new shares can be created to meet investor demand and the fund will cancel shares of investors who exit the fund.


Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.